Nebulized Budesonide
Nebulized Budesonide is a pharmaceutical drug with 4 clinical trials. Historical success rate of 100.0%.
Success Metrics
Based on 2 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
0
Mid Stage
4
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
100.0%
2 of 2 finished
0.0%
0 ended early
0
trials recruiting
4
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Two Doses of the Intravenous Magnesium Sulfate Versus the Standard Single Dose ,With/ Without the Nebulized Budesonide For the Management of the Severe Asthma Exacerbation in the Emergency Room; A Randomized Controlled Trial.
Comparison of Nebulized Budesonide and Intranasal Budesonide Spray in Children With Adenotonsillar Hypertrophy
Effect of Nebulized Budesonide and Oral Corticosteroids on Wheezing Episode Relapse in Children
Effect of Budesonide on Exhaled Nitric Oxide in Asthmatic Children
Clinical Trials (4)
Two Doses of the Intravenous Magnesium Sulfate Versus the Standard Single Dose ,With/ Without the Nebulized Budesonide For the Management of the Severe Asthma Exacerbation in the Emergency Room; A Randomized Controlled Trial.
Comparison of Nebulized Budesonide and Intranasal Budesonide Spray in Children With Adenotonsillar Hypertrophy
Effect of Nebulized Budesonide and Oral Corticosteroids on Wheezing Episode Relapse in Children
Effect of Budesonide on Exhaled Nitric Oxide in Asthmatic Children
All 4 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 4